This industry works tirelessly to bring competitive drugs to market. With our manufacturing partners, we proudly deliver savings and access to high quality medicines to the VA, Dept. of Defense, and Indian Health Service populations.
In 2023, #generics and #biosimilars represented a whopping 90% of all prescriptions filled and only 13% of all drug spending in the U.S. In fact, generic & biosimilar medicines are the only aspect of healthcare that CONSISTENTLY deliver lower costs for patients! Learn more in AAM’s 2024 Savings Report: https://lnkd.in/e9xGNTfW #GRxBiosimsSavingsReport